Cargando…
Macrophage biomimetic nanocarriers for anti-inflammation and targeted antiviral treatment in COVID-19
BACKGROUND: The worldwide pandemic of COVID-19 remains a serious public health menace as the lack of efficacious treatments. Cytokine storm syndrome (CSS) characterized with elevated inflammation and multi-organs failure is closely correlated with the bad outcome of COVID-19. Hence, inhibit the proc...
Autores principales: | Tan, Qingqin, He, Lingjie, Meng, Xiaojun, Wang, Wei, Pan, Hudan, Yin, Weiguo, Zhu, Tianchuan, Huang, Xi, Shan, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190731/ https://www.ncbi.nlm.nih.gov/pubmed/34112203 http://dx.doi.org/10.1186/s12951-021-00926-0 |
Ejemplares similares
-
Antiviral and Anti‐Inflammatory Treatment with Multifunctional Alveolar Macrophage‐Like Nanoparticles in a Surrogate Mouse Model of COVID‐19
por: Li, Bin, et al.
Publicado: (2021) -
Nanovesicles derived from bispecific CAR-T cells targeting the spike protein of SARS-CoV-2 for treating COVID-19
por: Zhu, Tianchuan, et al.
Publicado: (2021) -
Biomimetic Nanocarriers for Cancer Target Therapy
por: Guido, Clara, et al.
Publicado: (2020) -
Implications of biomimetic nanocarriers in targeted drug delivery
por: Al-Hetty, Hussein Riyadh Abdul Kareem, et al.
Publicado: (2023) -
Homotypic Cell Membrane-Cloaked Biomimetic Nanocarrier for the Targeted Chemotherapy of Hepatocellular Carcinoma
por: Liu, Xiaojun, et al.
Publicado: (2019)